Literature DB >> 16306342

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Jerry P Palmer1, Christiane S Hampe, Harvey Chiu, Amit Goel, Barbara M Brooks-Worrell.   

Abstract

Diabetes is classified clinically into two types: type 1 and type 2 diabetes. Type 1 diabetes is an autoimmune diabetes, whereas, in contrast, type 2 diabetes is nonautoimmune. However, there is a group of phenotypic adult type 2 diabetic patients ( approximately 10%) who have islet autoantibodies similar to type 1 diabetes. These patients are said to have latent autoimmune diabetes in adults (LADA) or type 1.5 diabetes. T-cells reacting with islet proteins have been demonstrated in type 1 and type 1.5 diabetic patients. In contrast, classic autoantibody-negative type 2 diabetic patients are also negative for T-cell responses to islet proteins. Therefore, we questioned whether type 1 and type 1.5 diabetes are similar or different autoimmune diseases. We have investigated the immunological and metabolic differences between type 1, type 1.5, and classic type 2 diabetic patients. We have identified autoantibody differences, differences in islet proteins recognized by T-cells, and differences in insulin resistance. We have also identified a small group of patients who have T-cells responsive to islet proteins but who are autoantibody negative. These patients appear to be similar to type 1.5 patients in having decreased stimulated C-peptide values. These immunological differences between type 1 and type 1.5 diabetes suggest at least partially distinct disease processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306342     DOI: 10.2337/diabetes.54.suppl_2.s62

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

Review 1.  Clinical Recommendations for the Use of Islet Cell Autoantibodies to Distinguish Autoimmune and Non-Autoimmune Gestational Diabetes.

Authors:  Kadri Haller-Kikkatalo; Raivo Uibo
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!

Authors:  O Rolandsson; J P Palmer
Journal:  Diabetologia       Date:  2010-03-25       Impact factor: 10.122

3.  Latent autoimmune diabetes in adults (LADA)--more than a name.

Authors:  L Groop; T Tuomi; M Rowley; P Zimmet; I R Mackay
Journal:  Diabetologia       Date:  2006-07-04       Impact factor: 10.122

Review 4.  Approach to the patient with atypical diabetes.

Authors:  Devin W Steenkamp; Sara M Alexanian; Elliot Sternthal
Journal:  CMAJ       Date:  2014-01-06       Impact factor: 8.262

Review 5.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

6.  Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.

Authors:  Rodolfo José Chaparro; Yves Konigshofer; Georg F Beilhack; Judith A Shizuru; Hugh O McDevitt; Yueh-Hsiu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

7.  The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.

Authors:  M Hillman; C Törn; M Landin-Olsson
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Clustering of immunological, metabolic and genetic features in latent autoimmune diabetes in adults: evidence from principal component analysis.

Authors:  Giovanni Mario Pes; Alessandro Palmerio Delitala; Alessandra Errigo; Giuseppe Delitala; Maria Pina Dore
Journal:  Intern Emerg Med       Date:  2015-11-26       Impact factor: 3.397

9.  Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study.

Authors:  Elin Pettersen; Frank Skorpen; Kirsti Kvaløy; Kristian Midthjell; Valdemar Grill
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

Review 10.  Beta-cell protection and therapy for latent autoimmune diabetes in adults.

Authors:  Simona Cernea; Raffaella Buzzetti; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.